CA1095416A - Pharmaceutical compositions comprising substituted phenyl-amino-alcohol and process for preparing these compositions - Google Patents

Pharmaceutical compositions comprising substituted phenyl-amino-alcohol and process for preparing these compositions

Info

Publication number
CA1095416A
CA1095416A CA279,790A CA279790A CA1095416A CA 1095416 A CA1095416 A CA 1095416A CA 279790 A CA279790 A CA 279790A CA 1095416 A CA1095416 A CA 1095416A
Authority
CA
Canada
Prior art keywords
amino
alcohol
pharmaceutical composition
substituted phenyl
glucuronic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA279,790A
Other languages
English (en)
French (fr)
Inventor
Claude Gillet
Andre Vincze
Romeo Roncucci
Joseph Roba
Georges Lambelin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Continental Pharma Inc
Original Assignee
Continental Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Continental Pharma Inc filed Critical Continental Pharma Inc
Application granted granted Critical
Publication of CA1095416A publication Critical patent/CA1095416A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
CA279,790A 1976-06-04 1977-06-03 Pharmaceutical compositions comprising substituted phenyl-amino-alcohol and process for preparing these compositions Expired CA1095416A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR76.17.110 1976-06-04
FR7617110A FR2353288A1 (fr) 1976-06-04 1976-06-04 Composition pharmaceutique hydrosoluble a base d'un compose amine comme produit actif

Publications (1)

Publication Number Publication Date
CA1095416A true CA1095416A (en) 1981-02-10

Family

ID=9174050

Family Applications (1)

Application Number Title Priority Date Filing Date
CA279,790A Expired CA1095416A (en) 1976-06-04 1977-06-03 Pharmaceutical compositions comprising substituted phenyl-amino-alcohol and process for preparing these compositions

Country Status (9)

Country Link
JP (1) JPS5318721A (sv)
BE (1) BE855320A (sv)
CA (1) CA1095416A (sv)
CH (1) CH622023A5 (sv)
DE (1) DE2724608C2 (sv)
FR (1) FR2353288A1 (sv)
GB (1) GB1569380A (sv)
NL (1) NL7706177A (sv)
SE (1) SE441183B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1198386B (it) * 1982-07-06 1988-12-21 Lepetit Spa Un prodotto a rilascio protratto contenente il suloctidile
DE3815273A1 (de) * 1988-05-05 1989-11-16 Draegerwerk Ag Mobile intensivbehandlungseinheit
AU5103898A (en) * 1996-11-05 1998-05-29 Alcon Laboratories, Inc. Polyhydroxy monocarboxylic and dicarboxylic acids and their lactones in ophthalmic compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH52A (de) * 1889-01-08 Emil Zetter Neuer Petroleumgas-Apparat für Heizzwecke
CH54A (fr) * 1889-01-08 Emile Mertz Appareil à humidifier et à rafraîchir l'air des salles de filatures, des malteries, des bateaux, des salles de théâtres, etc.
GB1390748A (en) * 1973-04-09 1975-04-16 Continental Pharma Alkyl and cycloalkylthiophenylalkylaminoalkanols their salts and the preparation thereof

Also Published As

Publication number Publication date
DE2724608A1 (de) 1977-12-22
FR2353288B1 (sv) 1978-12-15
BE855320A (fr) 1977-12-02
SE441183B (sv) 1985-09-16
DE2724608C2 (de) 1986-09-18
JPS6126526B2 (sv) 1986-06-20
JPS5318721A (en) 1978-02-21
FR2353288A1 (fr) 1977-12-30
NL7706177A (nl) 1977-12-06
CH622023A5 (en) 1981-03-13
GB1569380A (en) 1980-06-11
SE7706481L (sv) 1977-12-05

Similar Documents

Publication Publication Date Title
US3658966A (en) Methods of treating hypertension
WO1985003507A2 (en) Metallicenium salts and utilization thereof as cytostatic agents for combatting cancer
CA1095416A (en) Pharmaceutical compositions comprising substituted phenyl-amino-alcohol and process for preparing these compositions
CA1069125A (en) 4-imino-1,3-diazabicyclo-(3.1.0) hexan-2-one
US4176193A (en) Therapeutic isobutyramides
DE69600225T2 (de) N,N'-di(Aralkyl)N,N'-di(carboxyalkyl)alkylendiaminderivate, N-(Aralkyl)N'-(carboxyalkyl)N,N'-di(carboxyalkyl)alkylendiaminderivate und N,N"-di(Aralkyl)N,N',N"-tri(carboxyalkyl)dialkylentriaminderivate und ihre Verwendung in Pharmazie und Kosmetik
DE2432392C3 (de) Tris-(2-hydroxyäthyl)-ammonium-orthokresoxyazetat, Verfahren zu dessen Herstellung und Arzneimittel auf dessen Basis
EP0923932B1 (en) Composition containing antitumor agent
CH644596A5 (de) 2,6-dimethyl-1,4-dihydropyridin-3,5-dikarbonsaeureester und verfahren zu ihrer herstellung.
DE2008693A1 (de) Neue 'Pyrazoline
US4100287A (en) Pyrimidine derivative
DE69328357T2 (de) Komplex von 2-aminoäthansulfonsäure und zink
US3810986A (en) Novel method and composition
US4148898A (en) N-oxy-ajmaline and the use thereof in treating cardiovascular disorders
US3702865A (en) Ethyl 2-methyl-2-n-propylamino-propyl succinate
AT213395B (de) Verfahren zur Herstellung des neuen β-Hydroxybuttersäure-cyclohexylamids
DE2221281A1 (de) Pyrazolderivate und Verfahren zu ihrer Herstellung
JPS589119B2 (ja) アジマリンのカルデノリドおよびブファジエノリド誘導体およびそれらの製法
US2766175A (en) Mersalyl diuretic solutions stabilized with methylated glycines
US3733353A (en) Aminocyclohexanemethyl benzoates
KR890000381B1 (ko) 아실아미노페놀 유도체의 제조방법
CA2247329C (en) Composition containing antitumor agent
KR790001523B1 (ko) 벤질아민의 제조방법
GB2070004A (en) 1-Aminoadamantane D,L-2- acetamido-3-phenylpropionate
DE2215999A1 (de) Nitroimidazolyl-triazolo-pyridazine und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
MKEX Expiry